Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride
International Journal of Creative and Open Research in Engineering and Management · 26.05.2026 · 02 (05) · 1-14
DOI: 10.55041/ijcope.v2i5.753 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Creative and Open Research in Engineering and Management, online erschienen am 26.05.2026. Verfasst von Kailash R. Biyani Kailash R. Biyani und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The present study reports the development and comprehensive ICH Q2(R1)-compliant validation of a UV spectrophotometric analytical method for Propranolol Hydrochloride (Propranolol HCl), combined with the design and evaluation of sustained release (SR) hydrophilic matrix tablets. Propranolol HCl is a BCS Class I, non-selective β-adrenergic receptor blocker with a short biological half-life (3–6 hours) and extensive first-pass hepatic metabolism, necessitating multiple daily dosing and causing peak-to-trough plasma fluctuations. Seven SR matrix tablet formulations (F1–F7) containing 80 mg Propranolol HCl were prepared by wet granulation using varying ratios of HPMC K4M and HPMC K15M as rate-controlling polymers. The validated UV method (λmax = 220 nm, 0.1N HCl) demonstrated excellent linearity over 2–24 µg/mL (r² = 0.9999), accuracy (% recovery 99.6–100.1%), and precision (%RSD < 1%). All formulations achieved sustained drug release over 12 hours; the Korsmeyer-Peppas model best described release kinetics (r² > 0.9951), with n values of 0.48–0.78 indicating anomalous diffusion-erosion transport. Formulation F4 (HPMC K4M:K15M = 50:50) was identified as optimal, achieving 88.5% cumulative drug release at 12 hours with near-zero-order kinetics. Accelerated stability studies at 40°C/75% RH for 3 months confirmed drug content ≥ 98.9% and consistent dissolution performance. The study demonstrates that integrated analytical validation and HPMC matrix optimization provide a reproducible, clinically relevant SR platform for improved cardiovascular pharmacotherapy. Keywords: Propranolol Hydrochloride, Sustained Release, HPMC K4M, HPMC K15M, ICH Q2(R1), UV Spectrophotometry, Matrix Tablets, Korsmeyer-Peppas, Wet Granulation.
Zitieren
APA
Biyani, K. R. B. K. R., Sheikh, A. A. S. A. A., Bhagwat, D. R. B. D. R., Kale, R. H. K. R. H., & Ingle, A. V. I. A. V. (2026). Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride. International Journal of Creative and Open Research in Engineering and Management, 02(05), 1-14. https://doi.org/10.55041/ijcope.v2i5.753
Vancouver
Biyani KRBKR, Sheikh AASAA, Bhagwat DRBDR, Kale RHKRH, Ingle AVIAV. Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride. International Journal of Creative and Open Research in Engineering and Management. 2026;02(05):1-14. doi:10.55041/ijcope.v2i5.753
BibTeX
@article{Biyani2026,
author = {Biyani, Kailash R. Biyani Kailash R. and Sheikh, Aijaz A. Sheikh Aijaz A. and Bhagwat, Diptee R. Bhagwat Diptee R. and Kale, Ravindra H. Kale Ravindra H. and Ingle, Aachal V. Ingle Aachal V.},
title = {Method Development and Validation of Sustained Release Tablets of Propranolol Hydrochloride},
journal = {International Journal of Creative and Open Research in Engineering and Management},
year = {2026},
volume = {02},
number = {05},
pages = {1--14},
doi = {10.55041/ijcope.v2i5.753}
}
EUVIMED